Immutep Receives Nasdaq Notice of Minimum Bid Price Deficiency

Immutep Limited (NASDAQ: IMMP) announced on April 30, 2026, that it received a written notification from The Nasdaq Stock Market LLC indicating that the company is not in compliance with the minimum bid price requirement. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of at least US$1.00 per share. The deficiency was triggered because the closing bid price of Immutep’s American Depositary Shares (ADS) remained below $1.00 for 30 consecutive business days ending April 24, 2026. The notification does not result in an immediate delisting. Immutep has been granted an initial compliance period of 180 calendar days, until October 26, 2026, to regain compliance. To do so, the closing bid price of its ADS must be at least $1.00 for a minimum of ten consecutive business days. The company stated it will monitor the bid price and consider options to resolve the deficiency. This notice does not affect the company's listing on the Australian Securities Exchange (ASX).